Leta Stetter Hollingworth was a trailblazing psychologist and champion of women’s rights. But a century after the 19th Amendment, equality has a long way to go.
Category: /daily-cover-stories
This Startup Might Finally Cure Sickle Cell Disease—After A Century Of Racist Neglect
The painful blood disorder, which mostly affects Black people, is just one of thousands of rare diseases that could be cured by Beam Therapeutics’ revolutionary gene editing technology.
Exclusive: Meet The Harvard Professor Who Became A Billionaire Thanks To Coronavirus
A decade ago, Timothy Springer made an investment on a fledgling biotech company. Now he talks about that bet and other investments.
Fueled By $500 Million In Federal Cash, Moderna Races To Make 1 Billion Doses Of An Unproven Cure
The company’s billionaire CEO has secured huge grants on the promise of a new class of mRNA vaccines, but nobody really knows if they will work.
Sweetleaf Collective: Compassionate Plant Based Healing For The People In 2020
Now we work with cultivators who have medicine to donate, linking them up with distributors who pick up the donation, labs who do the testing, and dispensaries and delivery services that dispense to Sweetleaf’s patients.
